Compounds > haloperidol

haloperidol and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine

haloperidol has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferré, S; Fuxe, K; Li, XM; Ogren, SO; Schwarcz, R; Snaprud, P1
Kanda, T; Nakamura, J; Shimada, J; Shiozaki, S; Suzuki, F1
Beilstein, MA; Chen, JF; Cuellar, B; Fink, JS; Grandy, DK; Hackett, E; Impagnatiello, F; Low, MJ; Moratalla, R; Ongini, E; Rubinstein, M; Schwarzschild, MA1
Akahane, A; Aoki, S; Iwashita, A; Matsuda, R; Matsuoka, N; Mihara, K; Mihara, T; Mitani, Y; Yamamoto, H; Yarimizu, J1
Jones-Cage, C; Stratford, TR; Wirtshafter, D1

Other Studies

5 other study(ies) available for haloperidol and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine

ArticleYear
Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.
    Psychopharmacology, 1994, Volume: 116, Issue:3

    Topics: Adenosine; Animals; Antihypertensive Agents; Binding, Competitive; Dopamine D2 Receptor Antagonists; Haloperidol; Kinetics; Male; Membranes; Motor Activity; Neostriatum; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Purinergic P1; Salicylamides; Theophylline

1994
KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.
    European journal of pharmacology, 1994, May-02, Volume: 256, Issue:3

    Topics: Adenosine; Administration, Oral; Animals; Antihypertensive Agents; Benserazide; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Mice; Phenethylamines; Purinergic Antagonists; Xanthines

1994
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Feb-13, Volume: 98, Issue:4

    Topics: Adenosine; Amphetamines; Animals; Caffeine; Catalepsy; Corpus Striatum; Dopamine Antagonists; Enkephalins; Gene Expression; Haloperidol; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic P1; RNA, Messenger

2001
Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 323, Issue:2

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Aminopyridines; Animals; CHO Cells; Cognition Disorders; Cricetinae; Cricetulus; Dopamine; Haloperidol; Humans; Male; Memory Disorders; Mice; Mice, Inbred C57BL; MPTP Poisoning; Phenethylamines; Piperazines; Rats; Rats, Inbred F344; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Scopolamine

2007
Differential effects of the adenosine A₂A agonist CGS-21680 and haloperidol on food-reinforced fixed ratio responding in the rat.
    Psychopharmacology, 2012, Volume: 220, Issue:1

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Behavior, Animal; Conditioning, Operant; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Phenethylamines; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reward

2012